Sivik Global Healthcare’s Becton Dickinson BDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,000
| Closed | -$3.88M | – | 37 |
|
|
2025
Q4 | $3.88M | Buy |
+20,000
| New | +$3.81M | 1.13% | 32 |
|
|
2024
Q4 | – | Sell |
-25,000
| Closed | -$6.03M | – | 41 |
|
|
2024
Q3 | $6.03M | Hold |
25,000
| – | – | 2.55% | 16 |
|
|
2024
Q2 | $5.84M | Buy |
25,000
+10,000
| +67% | +$2.36M | 2.1% | 19 |
|
|
2024
Q1 | $3.71M | Buy |
+15,000
| New | +$3.59M | 0.87% | 34 |
|
|
2023
Q3 | – | Sell |
-30,000
| Closed | -$7.92M | – | 37 |
|
|
2023
Q2 | $7.92M | Buy |
30,000
+15,000
| +100% | +$3.81M | 1.85% | 10 |
|
|
2023
Q1 | $3.71M | Buy |
+15,000
| New | +$3.67M | 1.6% | 32 |
|
|
2022
Q1 | – | Sell |
-17,938
| Closed | -$4.4M | – | 50 |
|
|
2021
Q4 | $4.4M | Sell |
17,938
-7,687
| -30% | -$1.84M | 1.89% | 25 |
|
|
2021
Q3 | $6.15M | Buy |
+25,625
| New | +$6.29M | 1.47% | 27 |
|
|
2021
Q2 | – | Sell |
-30,750
| Closed | -$7.29M | – | 50 |
|
|
2021
Q1 | $7.29M | Buy |
30,750
+2,562
| +9% | +$626K | 2.66% | 20 |
|
|
2020
Q4 | $6.88M | Buy |
28,188
+11,788
| +72% | +$2.75M | 2.81% | 19 |
|
|
2020
Q3 | $3.72M | Sell |
16,400
-1,806
| -10% | -$444K | 1.6% | 32 |
|
|
2020
Q2 | $4.25M | Buy |
+18,206
| New | +$4.39M | 1.41% | 31 |
|
|
2019
Q4 | – | Sell |
-20,500
| Closed | -$5.06M | – | 53 |
|
|
2019
Q3 | $5.06M | Sell |
20,500
-12,813
| -38% | -$3.16M | 2.55% | 21 |
|
|
2019
Q2 | $8.19M | Buy |
+33,313
| New | +$7.74M | 1.98% | 4 |
|
|
2018
Q2 | – | Sell |
-10,250
| Closed | -$2.17M | – | 63 |
|
|
2018
Q1 | $2.17M | Sell |
10,250
-7,214
| -41% | -$1.58M | 1.01% | 41 |
|
|
2017
Q4 | $3.65M | Sell |
17,464
-15,849
| -48% | -$3.32M | 1.35% | 31 |
|
|
2017
Q3 | $6.37M | Buy |
33,313
+7,688
| +30% | +$1.49M | 2.17% | 22 |
|
|
2017
Q2 | $4.88M | Buy |
25,625
+5,125
| +25% | +$936K | 1.79% | 23 |
|
|
2017
Q1 | $3.67M | Sell |
20,500
-5,125
| -20% | -$893K | 1.71% | 31 |
|
|
2016
Q4 | $4.14M | Buy |
25,625
+2,562
| +11% | +$425K | 1.97% | 22 |
|
|
2016
Q3 | $4.04M | Buy |
23,063
+2,563
| +13% | +$438K | 2.04% | 25 |
|
|
2016
Q2 | $3.39M | Sell |
20,500
-25,625
| -56% | -$4.1M | 1.69% | 31 |
|
|
2016
Q1 | $6.83M | Buy |
46,125
+35,875
| +350% | +$5.09M | 3.02% | 7 |
|
|
2015
Q4 | $1.54M | Sell |
10,250
-5,125
| -33% | -$738K | 0.73% | 55 |
|
|
2015
Q3 | $1.99M | Sell |
15,375
-10,250
| -40% | -$1.43M | 0.97% | 41 |
|
|
2015
Q2 | $3.54M | Sell |
25,625
-15,375
| -38% | -$2.12M | 1.23% | 30 |
|
|
2015
Q1 | $5.74M | Buy |
41,000
+307
| +0.8% | +$43K | 1.95% | 15 |
|
|
2014
Q4 | $5.53M | Buy |
+40,693
| New | +$5.2M | 2.24% | 14 |
|
|
2014
Q3 | – | Sell |
-11,864
| Closed | -$1.35M | – | 71 |
|
|
2014
Q2 | $1.37M | Buy |
+11,864
| New | +$1.35M | 0.69% | 57 |
|
|
2014
Q1 | – | Sell |
-13,325
| Closed | -$1.44M | – | 68 |
|
|
2013
Q4 | $1.44M | Buy |
+13,325
| New | +$1.38M | 1.02% | 45 |
|
Other funds holding BDX
VCM
VPM
Sivik Global Healthcare's BDX Position: Q1 2026 in Review
Sivik Global Healthcare sold out of Becton Dickinson (BDX) in Q1 2026, closing a stake of 20,000 shares — an estimated $3.88M sold.
Sivik Global Healthcare first reported a position in BDX in Q4 2013 and held it in 30 quarters. The position peaked at $8.19M in Q2 2019. 1,467 funds tracked by Wall St. Rank hold BDX as of Q1 2026.
- Sivik Global Healthcare reported no remaining Becton Dickinson position as of Q1 2026 after selling out during the quarter.
- Sivik Global Healthcare sold 20,000 Becton Dickinson shares in Q1 2026, an estimated $3.88M.
- Sivik Global Healthcare first reported a position in Becton Dickinson in Q4 2013 and held it in 30 quarters.
- Sivik Global Healthcare's Becton Dickinson position peaked at $8.19M in Q2 2019.
- 1,467 funds tracked by Wall St. Rank held Becton Dickinson as of Q1 2026.
Based on Sivik Global Healthcare's 13F filing for Q1 2026, filed 15 Apr 2026.